Imbruvica (ibrutinib tablets, capsules, and oral suspension) — Cigna
B-Cell Lymphoma (e.g., diffuse large B-cell lymphoma, HIV-related B-cell lymphoma, post-transplant lymphoproliferative disorders, high-grade B-cell lymphoma)
Initial criteria
- Patient is age ≥ 18 years
- Patient has tried at least one systemic regimen
Approval duration
1 year